Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma-Reference-Cited by-全球学者库

Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma

Published:2022-12-16 Issue:5 Volume:128 Page:907-917
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Ding Dong-yang,Gan Xiao-jie,Zhang Jia-ning,Hou Guo-jun,Tao Qi-fei,Sun Da-peng,Li Wen,Yang Yuan,Ding Wen-bin,Yu Jian,Liu Lei^ORCID,Yang Fu^ORCID,Zhou Wei-ping^ORCID,Yuan Sheng-xian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-02101-0.pdf

Reference41 articles.

1. Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. JAMA Surg. 2014;149:565–74.

2. Wirth TC, Vogel A. Surveillance in cholangiocellular carcinoma. Best Pract Res Clin Gastroenterol. 2016;30:987–99.

3. Moeini A, Sia D, Bardeesy N, Mazzaferro V, Llovet JM. Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma. Clin Cancer Res. 2016;22:291–300.

4. Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:353–63.

5. Varamo C, Peraldo-Neia C, Ostano P, Basirico M, Raggi C, Bernabei P, et al. Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine. Cancers (Basel). 2019;11:519.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombospondin-1 in drug activity and tumor response to therapies;Seminars in Cell & Developmental Biology;2024-03

2. Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance;Biomedicine & Pharmacotherapy;2023-12

3. Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma;Hepatoma Research;2023-08-23

4. Cisplatin in Liver Cancer Therapy;International Journal of Molecular Sciences;2023-06-29